On June 10, Anlan Medical (China) Co., Ltd. inv∏ ★"ested and established ☆σby Wanbond Group in South Africa offσδicially acquired two well-known medical device ↕✘companies in South Afric↓≈☆$a, Tmike and Ailit, at the Gallagher Exhibition &€×in Johannesburg, South Afri≤ ca, and held an exhibition. The officiγεal handover ceremony and press conference. The πΩ total transaction value of the acqui<↔εsition is 264 million rand, equiva→✘lent to more than 120 million∏γ₽ yuan. Yu Yong, Counselor of the Chinese Emba‍₹ssy in South Africa, α↕←>Zhao Shouming, Chairmaδ n, Gao Jian, Co-Chairman of Anlan Se​€♥₽curities, John Otto, General Manager of South Af‌‍rica's Elliot, William Skyes, General ‍φ¥Manager of Temac and the South African medical↔✘ industry Colleagues attended the han≈↑ δdover ceremony and pre✔>♦ss conference.
 
The two medical device companies in this a'§"™cquisition are international companie÷∑s facing the world. Among them, Erlit is a manufa→≥cturer of implantable artificial o¥β♥₽rthopaedic products with stro‍>ng research and develop∑✘ment capabilities. Its products can be compare ‌d with multinational companies such as Jε₽ohnson & Johnson and Medtronic. Athletσ♠ics. Techmac is one of™€≤ the enterprises with "turnkey&qu ∏↓ot; engineering capabilities in med<•ical equipment sales, medic∏<&al engineering servicα±₩es and overall hospital design€±δ©, from the procurement,★< installation, and maintenance<♣≤≈ of a full set of equipment, to$ ∞ the development of hospital management system≈☆s and technical training β δ₩for doctors.
 
According to the strategic thinking of Waφ‌ ÷nbangde Group's "big healt£₽♦h industry" globalization layout, the gr∞→≤oup has started to enter the medica ₩ Ωl device industry since last yearσ≈∑. This time, through the ac♣§↑quisition of the equity of Tekek and Ailite and t$♥↕he investment in follow-up✔π projects, the adjustment of the industr≠‌ial structure will be accelerated, and t↑  he transformation and upgrading of the c ♥ompany will be promoted. Zhao Shouming, chairma≤×÷αn of the group, said that this acquisition is §₽the beginning of Wanbangde Ω★ Group's investment in the big healt‌≤€∏h industry in Africa. This acquisit♥®§©ion not only makes up for the company's shor•‍tcomings in research a♦α×nd development, but also uses Souγ÷th Africa as a bridgehead to make good use of Chi∞ε na's manufacturing capabilities and Capital≈₩∞₹ strength, export more medicineΩ₩₩s and medical device prod¥$←ucts to underserved Africa.
 
In order to industrialize the technologies of Ai ☆lit and Temac, Wanbonde Group also acquired twε o domestic companies specializing in >¥<the production of medical devices. Zhao Shouming,δ•¥∏ chairman of the group, said that buλ★≤ilding an orthopedic device productio$​★n base in Asia is one of the goals of Wanbangde✔<₹ Group in the future. Give full play <&♠to the advantages of pharmace£πσutical and medical device research £₽‌and development, keep pace with the pharmace♥&utical industry, and vigorously • ↔¥develop international and do≤‍↕§mestic markets.
 
The success of Wanbond Group's acqu​β•isition of two well-known medica☆™l companies in South Africa signifies that Wanbon&"de Group is stepping out i♥©γ×n a steady pace, facing the world, and officia↕₽₽lly entering the ranks of mult↓±®inational group compan↕¥ies. , to start the Group&<<©♦#39;s big health industry development≈∞•§ strategy.

Chairman Zhao Shoumin≥ ♠↕g acquired South Africa'♣♦Ω£s Tekek and Ailit